THER has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
THER has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-05-12), Theralink Technologies's share price is $0.0001. Theralink Technologies does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Theralink Technologies's Price-to-Owner-Earnings or its related term are showing as below:
As of today (2025-05-12), Theralink Technologies's share price is $0.0001. Theralink Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.00. Therefore, Theralink Technologies's PE Ratio (TTM) for today is At Loss.
As of today (2025-05-12), Theralink Technologies's share price is $0.0001. Theralink Technologies's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.00. Therefore, Theralink Technologies's PE Ratio without NRI for today is At Loss.
The historical data trend for Theralink Technologies's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theralink Technologies Annual Data | |||||||||||||||||||||
Trend | Feb14 | Feb15 | Dec16 | Dec17 | Dec18 | Dec19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
Price-to-Owner-Earnings | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Theralink Technologies Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Theralink Technologies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Theralink Technologies's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Theralink Technologies's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Theralink Technologies's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 0.0001 | / | 0.00 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theralink Technologies (OTCPK:THER) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Theralink Technologies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Danica Holley | director | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Matthew Wilson Schwartz | director | 15000 W. 6TH AVENUE, SUITE 400, GOLDEN CO 80401 |
Chilcott, Iii Thomas E. | officer: Chief Financial Officer | 373 INVERNESS PARKWAY, ENGLEWOOD CO 80122 |
Jeffrey Busch | director | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Yvonne Fors | director | 1201 MONSTER RD SW STE 350, RENTON WA 98057 |
Michael I Ruxin | director, officer: Chief Executive Officer | HAEMONETICS CORPORATION INCORPORATED, 400 WOOD ROAD, BRAINTREE MA 02184 |
Avant Diagnostics, Inc | 10 percent owner | 1050 30TH STREET NW, SUITE 107, WASHINGTON DC 20007 |
Brian Gill Barnett | officer: Chief Executive Officer | 230 N SPRINGER, LOS ALTOS CA 94024 |
Robert Neal Holcomb | director | PO BOX 535, ROLLING FORK MS 39159 |
Volnie Carlos Fernando Alaman | 10 percent owner, officer: Chief Operating Officer-Vitel | MONTE PELVOUX 130 FLOOR 3, MEXICO O5 11000 |
Odabachian Manuel Cosme | director, 10 percent owner, officer: Global Operations GM-Vitel | MONTE PELVOUX 130 FLOOR 3, MEXICO O5 11000 |
Daniel S. Hoverman | director | C/O ONCBIOMUNE PHARMACEUTICALS INC.,, 11441 INDUSTRIPLEX BLVD, SUITE 190, BATON ROUGE LA 70809 |
Rice Charles L Jr | director | C/O ENTERGY CORPORATION LEGAL DEPT., 639 LOYOLA AVE., 26TH FLOOR, NEW ORLEANS LA 70113 |
Andrew Albert Kucharchuk | director, officer: CFO & President | 549 MILGATE PLACE, BATON ROUGE LA 70810 |
Jonathan Frederick Head | director, officer: Chief Executive Officer | 6144 HAGERSTOWN DRIVE, BATON ROUGE LA 70817 |
From GuruFocus
By PRNewswire PRNewswire • 12-01-2022
By Marketwired • 11-03-2023
By PRNewswire PRNewswire • 07-25-2022
By PRNewswire PRNewswire • 03-28-2022
By PRNewswire PRNewswire • 11-28-2022
By PRNewswire PRNewswire • 06-15-2022
By PRNewswire PRNewswire • 11-14-2022
By PRNewswire PRNewswire • 07-05-2022
By PRNewswire PRNewswire • 01-09-2023
By PRNewswire PRNewswire • 09-29-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.